Friedl-Naderer Johanna - Insider Non-Derivative Transactions at Dyne Therapeutics, Inc. (DYN) - (SEC)
Updated on January 3, 2026.
According to recent SEC insider information filed on Dec 5, 2025, Friedl-Naderer Johanna's relationship to Dyne Therapeutics, Inc. (DYN) is Officer (Chief Commercial Officer), and currently has 94,729 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other DYN insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Friedl-Naderer Johanna - Insider Non-Derivative Transactions of DYN Common Stock
Friedl-Naderer Johanna - Insider Non-Derivative Transactions at DYN
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 6, 2025 | Sell -- (Common Stock) | 144 | 20.72 | 94729 |
| Sep 6, 2025 | Sell -- (Common Stock) | 144 | 13.41 | 94873 |
| Sep 5, 2025 | Sell -- (Common Stock) | 894 | 13.27 | 95017 |
| Jun 6, 2025 | Sell -- (Common Stock) | 146 | 13.35 | 95911 |
| Mar 14, 2025 | Sell -- (Common Stock) | 143 | 12.12 | 96057 |
| Dec 5, 2024 | Acquisition -- (Common Stock) | 37800 | 0 | 96200 |
| Sep 4, 2024 | Acquisition -- (Common Stock) | 58400 | 0 | 58400 |